Comparison of the effectiveness of ocrelizumab vs interferons, fingolimod and natalizumab on relapses in relapsing-remitting multiple sclerosis

---

Roos I., Sharmin S., Ozakbas S., Horakova D., Havrdova E. K., Boz C., ...More

MULTIPLE SCLEROSIS JOURNAL, vol.27, no.2_SUPPL, pp.778-780, 2021 (SCI-Expanded, Scopus)

• Publication Type: Article / Abstract
• Volume: 27 Issue: 2_SUPPL
• Publication Date: 2021
• Journal Name: MULTIPLE SCLEROSIS JOURNAL
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, PASCAL, BIOSIS, EMBASE, MEDLINE
• Page Numbers: pp.778-780
• Dokuz Eylül University Affiliated: Yes